The Diabetes Prize for Excellence is an international prize awarded annually by the European Association for the Study of Diabetes (EASD)[1] in collaboration with the Novo Nordisk Foundation. The award recognizes extraordinary research at the intersection of obesity and diabetes and highlights breakthrough discoveries that improve the understanding and treatment of these diseases.[2]
The award was established in 2015[3] to highlight the link between obesity and type 2 diabetes, two global health challenges that often occur together. EASO and the Novo Nordisk Foundation want to use the award to promote research that improves treatment options and reduces the incidence of these diseases.[4]
For nomination of the award, the recipient must be selected on the basis of:[5]
Proposals for candidates are received globally and assessed by an expert panel appointed by EASO and the Novo Nordisk Foundation.
Since its establishment in 2015, the following individuals have received the award:
| 2015 | Sir S. O’Rahilly | United Kingdom | |
| 2016 | A. Hattersley | United Kingdom | |
| 2017 | P.E. Scherer | United States | |
| 2018 | Gökhan Hotamışlıgil[6] | Turkey | |
| 2019 | D.J. Drucker | Canada | |
| 2020 | J.C. Brüning | Germany | |
| 2021 | J.A. Todd | United Kingdom | |
| 2022 | A.-G. Ziegler | Germany | |
| 2023 | R. Hovorka | United Kingdom | |
| 2024 | J.R. Zierath | Sweden |